STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $176,000 | -73.4% | 20,595 | -72.5% | 0.13% | -64.2% |
Q3 2015 | $662,000 | -25.0% | 75,000 | 0.0% | 0.37% | -47.6% |
Q2 2015 | $883,000 | -18.6% | 75,000 | 0.0% | 0.70% | -23.1% |
Q1 2015 | $1,085,000 | -9.7% | 75,000 | +6.5% | 0.91% | -23.5% |
Q4 2014 | $1,201,000 | – | 70,400 | – | 1.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 453,000 | $4,168,000 | 1.58% |
Eventide Asset Management | 1,086,400 | $9,995,000 | 0.62% |
SPHERA FUNDS MANAGEMENT LTD. | 300,000 | $2,760,000 | 0.47% |
Lyon Street Capital, LLC | 125,595 | $1,155,000 | 0.46% |
CARL DOMINO INC | 26,000 | $239,000 | 0.28% |
PURA VIDA INVESTMENTS, LLC | 60,000 | $552,000 | 0.22% |
KNOTT DAVID M | 41,692 | $384,000 | 0.16% |
SABBY MANAGEMENT, LLC | 187,500 | $1,725,000 | 0.11% |
FARALLON CAPITAL MANAGEMENT LLC | 1,157,500 | $10,649,000 | 0.11% |
Telemetry Investments, L.L.C. | 25,000 | $230,000 | 0.11% |